Skip to main content
. 2024 Nov 13;46(11):12866–12885. doi: 10.3390/cimb46110766

Figure 8.

Figure 8

Treatment responsiveness evaluation. Predicted responsiveness to chemical drugs cisplatin (A), gemcitabine (B), paclitaxel (C), and vinblastine (D) in BLAC. Responsiveness to targeted drugs erlotinib (E) and sunitinib (F) in BLAC. (GJ). Tide scores in high- and low-risk groups.